Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Ritu Baral's Stock Ratings
TD Cowen Analyst
Ritu Baral is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/13/2025
Overall Average Return
-22.8%
Smart Score
Overall Average Return Percentile
11th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/05/2025 | PVLA | Buy Now | Palvella Therapeutics | $20.75 | 112.05% | Ritu Baral34% | → $44 | Initiates | → Buy | Get Alert |
| 11/21/2024 | SAGE | Buy Now | Sage Therapeutics | $6.59 | 36.57% | Ritu Baral34% | $10 → $9 | Maintains | Hold | Get Alert |
| 11/18/2024 | SPRO | Buy Now | Spero Therapeutics | $0.70 | — | Ritu Baral34% | — | Downgrade | Buy → Hold | Get Alert |
| 11/18/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | — | Ritu Baral34% | — | Downgrade | Buy → Hold | Get Alert |
| 10/21/2024 | RNA | Buy Now | Avidity Biosciences | $29.93 | 160.61% | Ritu Baral34% | $56 → $78 | Maintains | Buy | Get Alert |
| 10/21/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $266.86 | 39.02% | Ritu Baral34% | $282 → $371 | Maintains | Buy | Get Alert |
| 08/09/2024 | INSM | Buy Now | Insmed | $65.71 | 49.14% | Ritu Baral34% | $75 → $98 | Maintains | Buy | Get Alert |
| 08/06/2024 | SPRO | Buy Now | Spero Therapeutics | $0.70 | — | Ritu Baral34% | — | Upgrade | Hold → Buy | Get Alert |
| 07/30/2024 | SAGE | Buy Now | Sage Therapeutics | $6.59 | 51.75% | Ritu Baral34% | $16 → $10 | Downgrade | Buy → Hold | Get Alert |
| 07/09/2024 | MORF | Buy Now | Morphic Holding | — | — | Ritu Baral34% | — | Downgrade | Buy → Hold | Get Alert |
| 06/25/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $266.86 | 5.67% | Ritu Baral34% | $260 → $282 | Maintains | Buy | Get Alert |
| 05/29/2024 | INSM | Buy Now | Insmed | $65.71 | 1.96% | Ritu Baral34% | $45 → $67 | Maintains | Buy | Get Alert |
| 04/18/2024 | SAGE | Buy Now | Sage Therapeutics | $6.59 | 142.79% | Ritu Baral34% | $30 → $16 | Maintains | Buy | Get Alert |
| 03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $295.36 | 32.04% | Ritu Baral34% | $349 → $390 | Maintains | Outperform | Get Alert |
| 02/28/2024 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | Ritu Baral34% | $4 → $1.55 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/08/2023 | SAGE | Buy Now | Sage Therapeutics | $6.59 | 324.89% | Ritu Baral34% | $105 → $28 | Maintains | Outperform | Get Alert |
| 08/08/2023 | SGMT | Buy Now | Sagimet Biosciences | $3.08 | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 03/22/2023 | SRPT | Buy Now | Sarepta Therapeutics | $36.60 | 378.14% | Ritu Baral34% | $125 → $175 | Maintains | Outperform | Get Alert |
| 01/11/2023 | ALBO | Buy Now | Albireo Pharma | — | — | Ritu Baral34% | $68 → $48 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/21/2022 | INSM | Buy Now | Insmed | $65.71 | -19.34% | Ritu Baral34% | $56 → $53 | Maintains | Outperform | Get Alert |
| 10/18/2022 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | Ritu Baral34% | $32 → $9 | Maintains | Outperform | Get Alert |
| 08/16/2022 | APTX | Buy Now | Aptinyx | — | — | Ritu Baral34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/09/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | Ritu Baral34% | $67 → $68.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/08/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.20 | 22.09% | Ritu Baral34% | $32 → $21 | Maintains | Outperform | Get Alert |
| 05/04/2022 | SPRO | Buy Now | Spero Therapeutics | $0.70 | — | Ritu Baral34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/19/2022 | ANTX | Buy Now | AN2 Therapeutics | $1.10 | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 11/23/2021 | SPRB | Buy Now | Spruce Biosciences | $0.07 | — | Ritu Baral34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/23/2021 | RLYB | Buy Now | Rallybio | $0.30 | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 07/20/2021 | GHRS | Buy Now | GH Research | $9.26 | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 07/13/2021 | ATAI | Buy Now | ATAI Life Sciences | $1.43 | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 07/13/2021 | ATAI | Buy Now | ATAI Life Sciences | $1.43 | — | Ritu Baral34% | — | Initiates | → Buy | Get Alert |
| 06/15/2021 | SAGE | Buy Now | Sage Therapeutics | $6.59 | 1493.32% | Ritu Baral34% | $100 → $105 | Maintains | Outperform | Get Alert |
| 06/08/2021 | VERA | Buy Now | Vera Therapeutics | $22.56 | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 03/02/2021 | TERN | Buy Now | Terns Pharma | $2.92 | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 11/30/2020 | SAGE | Buy Now | Sage Therapeutics | $6.59 | 1417.45% | Ritu Baral34% | $96 → $100 | Maintains | Outperform | Get Alert |
| 11/03/2020 | SPRB | Buy Now | Spruce Biosciences | $0.07 | 67075.57% | Ritu Baral34% | → $44 | Initiates | → Outperform | Get Alert |
| 10/06/2020 | MYOK | Buy Now | MyoKardia | — | — | Ritu Baral34% | $145 → $225 | Downgrade | Outperform → Market Perform | Get Alert |
| 06/30/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Ritu Baral34% | $149 → $47 | Downgrade | Outperform → Market Perform | Get Alert |
| 06/29/2020 | PLRX | Buy Now | Pliant Therapeutics | $1.41 | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 11/26/2018 | ORTX | Buy Now | Orchard Therapeutics | — | — | Ritu Baral34% | → $27 | Initiates | → Outperform | Get Alert |
| 08/13/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $266.86 | -44.91% | Ritu Baral34% | $157 → $147 | Maintains | Outperform | Get Alert |
| 07/02/2018 | ASNS | Buy Now | Actelis Networks | $0.72 | — | Ritu Baral34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/12/2018 | AXON | Buy Now | Axon Enterprise | $729.08 | — | Ritu Baral34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/11/2017 | ASNS | Buy Now | Actelis Networks | $0.72 | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 11/27/2017 | ALNA | Buy Now | Allena Pharmaceuticals | — | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 11/27/2017 | SPRO | Buy Now | Spero Therapeutics | $0.70 | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 08/16/2017 | ALBO | Buy Now | Albireo Pharma | — | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 06/01/2017 | MGEN | Buy Now | Miragen Therapeutics | — | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 02/03/2017 | AXON | Buy Now | Axovant Sciences Ltd. Common Shares | $729.08 | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 01/09/2017 | TIG | Buy Now | Trean Insurance Group | — | — | Ritu Baral34% | — | Initiates | → Outperform | Get Alert |
| 05/31/2016 | ICPT | Buy Now | Intercept Pharma | — | — | Ritu Baral34% | $212 → $215 | Maintains | Outperform | Get Alert |
| 11/23/2015 | MYOK | Buy Now | MyoKardia | — | — | Ritu Baral34% | → $24 | Initiates | → Outperform | Get Alert |
| 09/08/2015 | GBT | Buy Now | Global Blood Therapeutics | — | — | Ritu Baral34% | → $80 | Initiates | → Outperform | Get Alert |
| 02/27/2015 | ALNY | Buy Now | Alnylam Pharmaceuticals | $266.86 | -43.79% | Ritu Baral34% | → $150 | Initiates | → Outperform | Get Alert |
| 09/05/2014 | ICPT | Buy Now | Intercept Pharma | — | — | Ritu Baral34% | → $420 | Initiates | → Outperform | Get Alert |
